GSK (MEX:GSKN) Dividend Payout Ratio: 0.42 (As of Mar. 2026) — 53% Below Median


MEX:GSKN GSK PLC MEX:GSKN
73 GF Score
Price MXN901.11
GF Value MXN818.82
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is GSK Dividend Payout Ratio?

GSK MEX:GSKN 73 Dividend Payout Ratio is 0.42 as of Mar. 2026, which is 53% below its 10-year median of 0.89. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 443 Drug Manufacturers companies, GSK ranks worse than 61.85% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. GSK's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.42.

The historical rank and industry rank for GSK's Dividend Payout Ratio or its related term are showing as below:

MEX:GSKN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.43   Med: 0.89   Max: 1.47
Current: 0.46

During the past 13 years, the highest Dividend Payout Ratio of GSK was 1.47. The lowest was 0.43. And the median was 0.89.

MEX:GSKN's Dividend Payout Ratio is ranked worse than
61.85% of 443 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs MEX:GSKN: 0.46

As of today (2026-06-24), the Dividend Yield % of GSK is 3.55%.

During the past 13 years, the highest Trailing Annual Dividend Yield of GSK was 8.35%. The lowest was 2.89%. And the median was 6.02%.

GSK's Dividends per Share for the months ended in Mar. 2026 was MXN8.52.

During the past 12 months, GSK's average Dividends Per Share Growth Rate was 8.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -5.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -10.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -5.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GSK was 62.10% per year. The lowest was -17.70% per year. And the median was 4.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

GSK (MEX:GSKN) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

GSK Dividend Payout Ratio Related Terms

GSK Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for GSK's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Dividend Payout Ratio Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 0.66 0.43 0.66 0.45

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.46 0.32 1.05 0.42

MEX:GSKN vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, GSK's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GSK Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Dividend Payout Ratio falls into.


MEX:GSKN
73GF Score
GSK PLC MEX:GSKN
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

GSK's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=31.143/ 69.948
=0.45

GSK's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=8.518/ 20.485
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.42 mean?
GSK (MEX:GSKN) has a Dividend Payout Ratio of 0.42 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GSK and its competitors. This is 53% below median its historical median of 0.89. Over the past decade, GSK's Dividend Payout Ratio has ranged from 0.43 to 1.47. According to the industry distribution chart, GSK ranks #274 out of 443 companies in the Drug Manufacturers industry, placing it in the top 61.9%.
Is GSK's Dividend Payout Ratio too high?
GSK's current Dividend Payout Ratio of 0.42 is 53% below median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 1.47. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. GSK's value of 0.42 is 10.5% above this industry median. Based on the distribution chart, GSK ranks #274 out of 443 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GSK ranks #274 out of 443 companies for Dividend Payout Ratio. This places GSK in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. GSK's value of 0.42 is 10.5% above this benchmark. Historically, GSK's own Dividend Payout Ratio has ranged from 0.43 to 1.47 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 0.38, GSK has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 443 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GSK's current Dividend Payout Ratio of 0.42 is 10.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GSK and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSK's current Dividend Payout Ratio is 0.42, which is 53% below median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current Dividend Payout Ratio is 0.42, which is 53% below median its 10-year median of 0.89 and 10.5% above the Drug Manufacturers industry median of 0.38. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For GSK (MEX:GSKN), the current Dividend Payout Ratio is 0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (MEX:GSKN) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82. GuruFocus considers GSK to be Fairly Valued.

Key valuation signals for MEX:GSKN:

  • Dividend Payout Ratio: 0.42 (53% below median its 10-year median of 0.89)
  • GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
  • GF Score™: 73/100 with 1 warning sign
  • Industry Position: 10.5% above the Drug Manufacturers median (#274 of 443)

No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score

Get the complete analysis for MEX:GSKN

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN901.11
Price
MXN818.82
GF Value